Eton Pharmaceuticals Inc (NASDAQ: ETON) on Tuesday, plunged -8.28% from the previous trading day, before settling in for the closing price of $18.84. Within the past 52 weeks, ETON’s price has moved between $3.18 and $21.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 109.83%. The company achieved an average annual earnings per share of 397.78%. With a float of $25.33 million, this company’s outstanding shares have now reached $26.82 million.
Let’s determine the extent of company efficiency that accounts for 31 employees. In terms of profitability, gross margin is 58.49%, operating margin of -4.69%, and the pretax margin is -9.3%.
Eton Pharmaceuticals Inc (ETON) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Eton Pharmaceuticals Inc is 5.53%, while institutional ownership is 52.77%. The most recent insider transaction that took place on Jun 03 ’25, was worth 3,780,000. Before that another transaction happened on Oct 23 ’24, when Company’s 10% Owner bought 10,000 for $7.98, making the entire transaction worth $79,814. This insider now owns 2,770,000 shares in total.
Eton Pharmaceuticals Inc (ETON) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 397.78% per share during the next fiscal year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Trading Performance Indicators
Eton Pharmaceuticals Inc (ETON) is currently performing well based on its current performance indicators. A quick ratio of 1.43 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.59. Likewise, its price to free cash flow for the trailing twelve months is 83.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 1.38 in one year’s time.
Technical Analysis of Eton Pharmaceuticals Inc (ETON)
Looking closely at Eton Pharmaceuticals Inc (NASDAQ: ETON), its last 5-days average volume was 0.6 million, which is a jump from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 14.64%. Additionally, its Average True Range was 1.25.
During the past 100 days, Eton Pharmaceuticals Inc’s (ETON) raw stochastic average was set at 59.59%, which indicates a significant increase from 13.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.45% in the past 14 days, which was higher than the 70.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.94, while its 200-day Moving Average is $12.14. However, in the short run, Eton Pharmaceuticals Inc’s stock first resistance to watch stands at $18.57. Second resistance stands at $19.86. The third major resistance level sits at $20.70. If the price goes on to break the first support level at $16.44, it is likely to go to the next support level at $15.60. Now, if the price goes above the second support level, the third support stands at $14.31.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Key Stats
Market capitalization of the company is 463.40 million based on 26,818K outstanding shares. Right now, sales total 39,010 K and income totals -3,820 K. The company made 17,280 K in profit during its latest quarter, and -1,570 K in sales during its previous quarter.
